Analysts Recommendations Old Dominion Freight Line, Inc.(NASDAQ:ODFL): Cytokinetics, Incorporated(NASDAQ:CYTK)

0
1

Old Dominion Freight Line, Inc. (ODFL) will report its next earnings on Feb 06 BMO. The company reported the earnings of $1.8/Share in the last quarter where the estimated EPS by analysts was $1.77/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 1.7%.

Many analysts are providing their Estimated Earnings analysis for Old Dominion Freight Line, Inc. and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $1.72/share. These analysts have also projected a Low Estimate of $1.61/share and a High Estimate of $1.78/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Old Dominion Freight Line, Inc. as 1 Billion. According to these analysts, the Low Revenue Estimate for Old Dominion Freight Line, Inc. is 985.8 Million and the High Revenue Estimate is 1.01 Billion. The company had Year Ago Sales of 994.01 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ODFL to be 4.3%. They are projecting Next Quarter growth of 7.41%. For the next 5 years, Old Dominion Freight Line, Inc. is expecting Growth of 11.2% per annum, whereas in the past 5 years the growth was 9.92% per annum.

Some buy side analysts are also providing their Analysis on Old Dominion Freight Line, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.58 and Average Volume (3 months) is 750.94 million. The company’s P/E (price to earnings) ratio is 28.27 and Forward P/E ratio of 23.14.

The company shows its Return on Assets (ROA) value of 17.2%. The Return on Equity (ROE) value stands at 23%. While it’s Return on Investment (ROI) value is 22.3%.

While looking at the Stock’s Performance, Old Dominion Freight Line, Inc. currently shows a Weekly Performance of -2.48%, where Monthly Performance is 5.37%, Quarterly performance is 13.23%, 6 Months performance is 31.31% and yearly performance percentage is 42.5%. Year to Date performance value (YTD perf) value is 14.03%. The Stock currently has a Weekly Volatility of 1.89% and Monthly Volatility of 2.11%.

Cytokinetics, Incorporated (CYTK) will report its next earnings on Mar 03 AMC. The company reported the earnings of $-0.5/Share in the last quarter where the estimated EPS by analysts was $-0.49/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -2%.

Many analysts are providing their Estimated Earnings analysis for Cytokinetics, Incorporated and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $-0.44/share. These analysts have also projected a Low Estimate of $-0.54/share and a High Estimate of $-0.26/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Cytokinetics, Incorporated as 7.19 Million. According to these analysts, the Low Revenue Estimate for Cytokinetics, Incorporated is 6.3 Million and the High Revenue Estimate is 7.8 Million. The company had Year Ago Sales of 9.38 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CYTK to be 12.5%. They are projecting Next Quarter growth of 11.11%. For the next 5 years, Cytokinetics, Incorporated is expecting Growth of -0.25% per annum, whereas in the past 5 years the growth was -3.59% per annum.

Some buy side analysts are also providing their Analysis on Cytokinetics, Incorporated, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.07 and Average Volume (3 months) is 849.59 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -59.1%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -130.2%.

While looking at the Stock’s Performance, Cytokinetics, Incorporated currently shows a Weekly Performance of -1.01%, where Monthly Performance is 16.11%, Quarterly performance is 53.93%, 6 Months performance is 9.21% and yearly performance percentage is 101.92%. Year to Date performance value (YTD perf) value is 38.55%. The Stock currently has a Weekly Volatility of 6.36% and Monthly Volatility of 5.25%.

SHARE